The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
D000284:Administration, Oral; D000818:Animals; D001362:Avoidance Learning; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects*; D003530:Cyprinidae / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006054:Goldfish / Q000378:metabolism*; D006651:Histocytochemistry; D007031:Hypothalamus / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007490:Iproniazid / Q000494:pharmacology; D008099:Liver / Q000378:metabolism; D008297:Male; D008568:Memory / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000008:administration & dosage / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D003336:Tectum Mesencephali / Q000378:metabolism; D014191:Tranylcypromine / Q000494:pharmacology
D001679:Biogenic Amines; D008996:Monoamine Oxidase Inhibitors; D011437:Propylamines; D012701:Serotonin; D014191:Tranylcypromine; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D007490:Iproniazid; D004298:Dopamine; D009638:Norepinephrine